Skip to main content
. 2012 Jul 11;103(9):1722–1729. doi: 10.1111/j.1349-7006.2012.02343.x

Table 1.

Drug sensitivity of gemtuzumab ozogamicin (GO)‐resistant HL‐60 variant human leukemia cell lines

Drug IC50
HL‐60 HL/GO HL/GO‐CSA
GO (μg/mL) 0.02 4.00 4.50
GO + MK571 (μg/mL) 0.02 3.95 2.90
MK571 (μM) 58.90 91.00 ND
DNR (μM) 0.03 0.13 0.15

Cells were incubated with various concentrations of GO with or without a minimally toxic concentration of MK571 (10 μM) for 72 h. The cells were also treated with daunorubicin (DNR) in the same manner. IC50 values were then determined by using the XTT assay. CSA, cyclosporine A; ND, not determined because the IC50 value was beyond the assay range due to the high degree of resistance.